Table 5.
Age at presentation | 1–72 months (mean 16.4 months)a |
Gender | Female 34 (56%); Male 27 (44%) |
Laterality | Unilateral 36;Bilateral 25 |
Nationality (in descending order) | Indonesia 29.5%, Vietnam 21.3%, Singapore 20%, Brunei 9.8%, Malaysia 6.6%, Myanmar 4.9%, Others(India, Sri Lanka, Papua new Guinea, Timor Leste & Russia) |
Grouping | Group A 1.16%, Group B 8.2%, Group C 26.3%, Group D 39.3%, Group E 24.7% |
Staging | Stage 0 83.6%, Stage I 8.2%, Stage II 1.6%, Stage III 1.6%, Stage IV 4.92% |
Interventions prior to referral | None 85%, Enucleation of 1 eye 11.5%, enucleation of both eyes 1.6%, Intravitreal anti-VEGF injection 1.6%. |
aExcluding one 24 year old patient with advanced unilateral disease at presentation